User menu

Teriparatide versus alendronate for treatment of glucocorticoid-induced osteoporosis: 36-month results

Bibliographic reference Saag, Kenneth G. ; Devogelaer, Jean-Pierre ; Zanchetta, Jose R. ; Adler, Robert A. ; Eastell, Richard ; et. al. Teriparatide versus alendronate for treatment of glucocorticoid-induced osteoporosis: 36-month results.72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals (San Francisco (Ca), Oct 24-29, 2008). In: Arthritis & Rheumatism, Vol. 58, no. 9, p. S939-S939 (2008)
Permanent URL http://hdl.handle.net/2078.1/59429
  1. Michaud, Arthritis Rheum, 48, 2750 (2003)
  2. Neumann, N Engl J Med, 353, 1516 (2006)
  3. Levinson, Arch Intern Med, 166, 16 (2006)
  4. Fries, Arthritis Rheum, 23, 137 (1980)
  5. Cost effectiveness in health and medicine (1996)
  6. Felson, Arthritis Rheum, 38, 727 (1995)
  7. Nixon, Stat Med, 26, 1237 (2006)
  8. Nixon, Rheumatology (Oxford), 46, 1140 (2007)
  9. Bansback, Ann Rheum Dis, 64, 995 (2005)
  10. Scott, Rheumatology (Oxford), 41, 899 (2002)
  11. Kobelt, Ann Rheum Dis, 63, 4 (2004)
  12. Brennan, Rheumatology (Oxford), 43, 62 (2004)
  13. Arias, Natl Vital Stat Rep, 53, 1 (2004)
  14. Symmons, Global burden of disease, 1 (2006)
  15. Shaw, Med Care, 43, 203 (2005)
  16. Stern, J Rheumatol, 31, 1538 (2004)
  17. Scott, Rheumatology (Oxford), 39, 122 (2000)
  18. Brazier, J Health Econ, 21, 271 (2002)
  19. Drummond, Methods for the economic evaluation of health care programmes (2005)
  20. Wailoo A Bansback N Brennan A Nixon R Michaud K Wolfe F 2006 http://www.shef.ac.uk/scharr/sections/heds/modelling/arthritis.html